Results 241 to 250 of about 103,608 (291)

Inhibition of the classical and lectin pathways restores K. kingae survival in rat serum.

Kevin A. Hernandez (22170777), Eric A. Porsch (9585171), Vanessa L. Muñoz (22170780), Joseph W. St. Geme III (12322861)   +3 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ficolins and the lectin complement pathway

Immunological Reviews, 2001
Summary:Ficolins, found in various tissues, are a group of proteins containing both a collagen‐like and a fibrinogen‐like domain. Recently, it was shown that ficolins present in serum are lectins with a common binding specificity for N‐acetylglucosamine (GlcNAc). The fibrinogen‐like domain is responsible for the carbohydrate binding.
M, Matsushita, T, Fujita
openaire   +2 more sources

Assays for the Mannan‐Binding Lectin Pathway

Current Protocols in Immunology, 2003
AbstractThis unit contains protocols that can be used to measure mannan‐binding lectin (MBL) levels and MBL pathway activity in human plasma or serum. Using a modification of the conventional ELISA, the detection reagent used in the methods described (e.g., an antibody or streptavidin) is labeled with Eu3+ instead of an enzyme.
Gadjeva, Mihaela, Thiel, Steffen, Jensenius, Jens Christian   +2 more
openaire   +2 more sources

Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis

Immunopharmacology, 1999
Lysis via the newly discovered lectin pathway of complement activation is reviewed. Mannan-coated erythrocytes sensitized with MBL are lysed in human serum containing Mg-EGTA via the lectin pathway by a process which requires alternative pathway amplification.
Y, Zhang, C, Suankratay, X H, Zhang, T F, Lint, H, Gewurz   +4 more
openaire   +2 more sources

The Lectin Pathway of Complement and Biocompatibility

2015
In modern health technologies the use of biomaterials in the form of stents, haemodialysis tubes, artificial implants, bypass circuits etc. is rapidly expanding. The exposure of synthetic, foreign surfaces to the blood and tissue of the host, calls for strict biocompatibility in respect to contact activation, the coagulation system and the complement ...
Hein, Estrid, Garred, Peter
openaire   +3 more sources

The Lectin Pathway of the Complement System

Microbiology and Immunology, 1996
One of the activities of animal lectins is the elimination of pathogens from a host. Serum mannose (or mannan)-binding protein (MBP) (25), in this capacity, recognizes mannose or N-acetylglucosamine on the surfaces of microorganisms. MBP is a member of the 'collectin' family (6), a group of C-type Ca2+-denendent animal lectins (3) which includes two ...
openaire   +2 more sources

Asparaginase inhibits the lectin pathway of complement activation

Molecular Immunology, 2018
Oncological treatment has been associated with an increased risk of infection, most often related to therapy-induced pancytopenia. However, limited research has been conducted on the effect of oncological therapy on the complement system, being part of the non-cellular innate immune system. This became the rationale for an observational clinical study (
Keizer, M. P., Aarts, C., Kamp, A. M., Caron, H. N., van de Wetering, M. D., Wouters, D., Kuijpers, T. W.   +6 more
openaire   +3 more sources

Activation of the lectin complement pathway by ficolins

International Immunopharmacology, 2001
Mannose-binding lectin (MBL), a serum lectin specific for mannose or N-acetylglucosamine (GlcNAc), which contains both a collagen-like domain and a carbohydrate-recognition domain (CRD), plays a role in innate immunity by acting as an opsonin and activating complement in association with MBL-associated serine protease (MASP) via the lectin pathway ...
M, Matsushita, Y, Endo, N, Hamasaki, T, Fujita   +3 more
openaire   +2 more sources